Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 USD | -4.55% | +7.35% | -37.71% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.71% | 77.68M | |
-0.53% | 103B | |
+3.38% | 96.73B | |
+1.66% | 21.31B | |
-16.32% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.92% | 13.68B | |
+6.03% | 13.44B | |
+22.76% | 10.98B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Sesen Bio Says Merger With Carisma Represents Best Value for Shareholders